Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis

Scandinavian Journal of Immunology

Volumn 47, Issue 6, 1998, Pages 582-590

  Matusevicius, D ^a   Kivisakk P ^a   Navikas, V ^a   Soderstrom M ^a   Fredrikson, S ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; MESSENGER RNA; PERFORIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN SITU HYBRIDIZATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PORE FORMING CYTOTOXIC PROTEINS; RNA, MESSENGER;

EID: 0031800907     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00344.x     Document Type: Article

References (49)

1. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996;85:299-302.
2. Romagnani S. Lymphokine production by human T cells in disease states. Immunol Today 1997;12:227-57.
3. Navikas V, Link H. Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Research 1996;45:322-33.
4. D'Andrea A, Rengaraju M, Valiante NM et al. Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J Exp Med 1992;176:1387-98.
5. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90:10188-92.
6. Olsson T, Wang W-Z, Höjeberg B et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J Clin Invest 1990;86:981-5.
7. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995;181:817-921.
8. Leonard JP, Waldburger KE, Goldman SJ. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J Exp Med 1995;181:381-6.
9. Windhagen A, Newcombe J, Dangond F et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin-12 in multiple sclerosis lesions. J Exp Med 1995;182:1985-96.
10. Nicoletti F, Patti F, Cocuzza C et al. Elevated levels of interleukin-12 in chronic progressive multiple sclerosis. J Neuroimmunol 1996;70:87-90.
11. Lowin B, Peitch MC, Tschopp J. Perform and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. In: Griffiths GM, Tschopp J, eds. Pathways for Cytolysis. Berlin: Springer-Verlag, 1995:1-25.
12. Liu C-C, Walsh CM, Young JD-E. Perforin: structure and function. Immunol Today 1995;16:194-201.
13. + lymphocytes in autoimmune disease. J Immunol 1989;143:3994-9.
14. Somoza N, Vargas F, Roura-Mir C et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 1994;153:1360-77.
15. Wu Z, Podack ER, McKenzie JM, Olsen KJ, Zakarija M. Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin Exp Immunol 1994;98:470-7.
16. Young LH, Joag SV, Lin PY et al. Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis. Am J Pathol 1992;140:1261-8.
17. Scolding NJ, Jones J, Compston DA, Morgan BP. Oligodendrocyte susceptibility to injury by T cell perform. Immunol 1990;70:6-10.
18. Sieling PA, Wang XH, Gately MK et al. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 1994;153:3639-47.
19. + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J Immunol 1994;24:3068-72.
20. Kägi D, Ledermann B, Burki K et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994;369:31-7.
21. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
23. Olsson T, Kostulas V, Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double antibody peroxidase labelling, and avidin-biotin amplification. Clin Chem 1984;30:1246-9.
24. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analysis in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385-90.
25. Deibler GE, Martensson RE, Kies MV. Large scale preparation of myelin basic protein from central nervous tissue of several animal species. Prep Biochem 1972;2:139-65.
26. Wang Z-Y, Qiao J, Link H. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J Neuroimmunol 1993;44:209-14.
27. Gubler U, Chua AD, Schoenhaut DS et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991;88:4143-7.
28. Shinkai Y, Yoshida MC, Maeda K et al. Molecular cloning and chromosomal assignment of a human perform (PFP) gene. Immunogenetics 1989;30:452-7.
29. Link J, Söderström M, Ljungdahl Å et al. Organ-specific autoantigens induce interferon-γ and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology 1994;44:728-34.
30. Wingren AG, Dahlenborg K, Bjorklund M et al. Monocyte regulated IFN-γ production in human T cells involves CD2 signaling. J Immunol 1993;151:1328-36.
31. Rieckmann P, Albrecht M, Kitze B et al. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis associated with disease activity. Ann Neurol 1995;37:82-8.
32. Sun JB, Olsson T, Wang WX et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 1991;21:1461-8.
33. Sun JB, Link H, Xiao BG et al. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 1991;146:1215-22.
34. Link H, Sun J-B, Wang Z-Y et al. Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1992;38:63-73.
35. Link J, Fredrikson S, Söderström M et al. Organ-specific autoantigens induce transforming growth factor-β inRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann Neurol 1994;35:197-203.
36. Navikas V, Link J, Palasik W et al. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand J Immunol 1995;41:171-8.
37. Navikas V, He B, Link J et al. Augmented expression of tumour necrosis factor-α and lymphotoxin mRNA in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996;119:213-23.
38. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-76.
39. Shu U, Kinuwa M, Wu CY et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995;25:1125-8.
40. + T cells via CD40 ligand. Proc Natl Acad Sci USA 1997;94:599-603.
41. Guzzinneli RT, Hieny S, Wynn TA, Wolf S, Sher A. Interleukin-12 is required for the T-cell independent induction of interferon-γ by an intracellular parasite and induces resistance in T-deficient hosts. Proc Natl Acad Sci USA 1993;90:6115-9.
42. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G. Cooperation of natural cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 1994;156:480-92.
43. Panitch HS, Hirsh L, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987;37:1097-102.
44. Vartanian T, Li Y, Zhao M, Stetanson K. Interferon-γ-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1995;1:732-43.
45. + T-cell responses to human myelin-derived peptides. Proc Natl Acad Sci USA 1994;91:10859-63.
46. Tsukada N, Matsuda M, Miyagi K, Yanagisawa N. Cytotoxicity of T cells for cerebral endothelium in multiple sclerosis. J Neurol Sci 1993;117:140-7.
47. Salcedo TW, Azzoni L, Wolf SF, Perussia B. Modulation of perform and granzyme messenger RNA expression in human natural killer cells. J Immunol 1993;151:2511-20.
48. Link J, He B, Navikas V et al. TGF-β suppresses autoantigen-induced expression of proinflammatory cytokines but not of IL-10 in multiple sclerosis and myasthenia gravis. J Neuroimmunol 1995;58:21-35.
49. Merill JE, Ignarro LJ, Shermann MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-41.